Patents by Inventor Jana BÖTHFÜR

Jana BÖTHFÜR has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Immunoassay for the diagnosis of viral infections
    Patent number: 11828758
    Abstract: A recombinant polypeptide can be used in the diagnosis of the presence of a Zika virus in a patient. The recombinant polypeptide includes SEQ ID NO: 1 or a variant thereof. The recombinant peptide may be a monomer, a dimer, or a hexamer.
    Type: Grant
    Filed: October 1, 2020
    Date of Patent: November 28, 2023
    Assignee: EUROIMMUN Medizinische Labordiagnostika AG
    Inventors: Katja Steinhagen, Andrea Deerberg, Erik Lattwein, Christiane Radzimski, Jana Böthfür
  • Assay for the diagnosis of viral infections
    Patent number: 11292816
    Abstract: A recombinant or chemically synthesized polypeptide includes SEQ ID NO: 1 or a variant thereof. A diagnostically useful carrier includes means for specifically capturing an antibody to SEQ ID NO: 1 in a sample from a subject. A kit includes the polypeptide or the diagnostically useful carrier. A method for diagnosing, prognosing, or monitoring the treatment of a virus, preferably Flavivirus, more preferably POWV infection includes detecting in the sample from a subject the presence or absence of an antibody to SEQ ID NO: 1 and/or an antibody to SEQ ID NO: 2. A polypeptide including SEQ ID NO: 1 and/or SEQ ID NO: 2, and/or a variant thereof is useful for the diagnosis. An IgM antibody to SEQ ID NO: 1 or means for specifically capturing an IgM class antibody to SEQ ID NO: 1 is useful for increasing the diagnostic reliability of an immunoassay for the diagnosis of a virus infection.
    Type: Grant
    Filed: February 22, 2019
    Date of Patent: April 5, 2022
    Assignee: EUROIMMUN Medizinische Labordiagnostika AG
    Inventors: Katja Steinhagen, Marc Pollmann, Claudia Messing, Oliver Klemens, Jana Boethfuer
  • AN IMMUNOASSAY FOR THE DIAGNOSIS OF VIRAL INFECTIONS
    Publication number: 20210033609
    Abstract: A recombinant polypeptide can be used in the diagnosis of the presence of a Zika virus in a patient. The recombinant polypeptide includes SEQ ID NO: 1 or a variant thereof. The recombinant peptide may be a monomer, a dimer, or a hexamer.
    Type: Application
    Filed: October 1, 2020
    Publication date: February 4, 2021
    Applicant: EUROIMMUN Medizinische Labordiagnostika AG
    Inventors: Katja Steinhagen, Andrea Deerberg, Erik Lattwein, Christiane Radzimski, Jana Böthfür
  • A novel assay for the diagnosis of viral infections
    Publication number: 20200385430
    Abstract: A recombinant or chemically synthesized polypeptide includes SEQ ID NO: 1 or a variant thereof. A diagnostically useful carrier includes means for specifically capturing an antibody to SEQ ID NO: 1 in a sample from a subject. A kit includes the polypeptide or the diagnostically useful carrier. A method for diagnosing, proposing, or monitoring the treatment of a virus, preferably Flavivirus, more preferably POWV infection includes detecting in the sample from a subject the presence or absence of an antibody to SEQ ID NO: 1 and/or an antibody to SEQ ID NO: 2. A polypeptide including SEQ NO: 1 and/or SEQ ID NO: 2, and/or a variant thereof is useful for the diagnosis. An IgIVI antibody to SEQ ID NO: 1 or means for specifically capturing an IgM class antibody to SEQ ID NO: 1 is useful for increasing the diagnostic reliability of an immunoassay for the diagnosis of a virus infection.
    Type: Application
    Filed: February 22, 2019
    Publication date: December 10, 2020
    Applicant: EUROIMMUN Medizinische Labordiagnostika AG
    Inventors: Katja Steinhagen, Marc Pollmann, Claudia Messing, Oliver Klemens, Jana Boethfuer
  • Immunoassay for the diagnosis of viral infections
    Patent number: 10837963
    Abstract: A recombinant polypeptide can be used in the diagnosis of the presence of a Zika virus in a patient. The recombinant polypeptide includes SEQ ID NO1 or a variant thereof, where the recombinant polypeptide is a monomer, a dimer, or a hexamer.
    Type: Grant
    Filed: February 22, 2017
    Date of Patent: November 17, 2020
    Assignee: EUROIMMUN Medizinische Labordiagnostika AG
    Inventors: Katja Steinhagen, Andrea Deerberg, Erik Lattwein, Christiane Radzimski, Jana Böthfür
  • AN IMMUNOASSAY FOR THE DIAGNOSIS OF VIRAL INFECTIONS
    Publication number: 20190383814
    Abstract: A recombinant polypeptide can be used in the diagnosis of the presence of a Zika virus in a patient. The recombinant polypeptide includes SEQ ID NO1 or a variant thereof, where the recombinant polypeptide is a monomer, a dimer, or a hexamer.
    Type: Application
    Filed: February 22, 2017
    Publication date: December 19, 2019
    Applicant: EUROIMMUN Medizinische Labordiagnostika AG
    Inventors: Katja STEINHAGEN, Andrea DEERBERG, Erik LATTWEIN, Christiane RADZIMSKI, Jana BÖTHFÜR